Correlation Between Bio Path and Immix Biopharma
Can any of the company-specific risk be diversified away by investing in both Bio Path and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Path and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Path Holdings and Immix Biopharma, you can compare the effects of market volatilities on Bio Path and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Path with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Path and Immix Biopharma.
Diversification Opportunities for Bio Path and Immix Biopharma
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Bio and Immix is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Bio Path Holdings and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and Bio Path is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Path Holdings are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of Bio Path i.e., Bio Path and Immix Biopharma go up and down completely randomly.
Pair Corralation between Bio Path and Immix Biopharma
Given the investment horizon of 90 days Bio Path Holdings is expected to under-perform the Immix Biopharma. In addition to that, Bio Path is 2.28 times more volatile than Immix Biopharma. It trades about -0.15 of its total potential returns per unit of risk. Immix Biopharma is currently generating about -0.07 per unit of volatility. If you would invest 218.00 in Immix Biopharma on October 22, 2024 and sell it today you would lose (14.00) from holding Immix Biopharma or give up 6.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bio Path Holdings vs. Immix Biopharma
Performance |
| Timeline |
| Bio Path Holdings |
| Immix Biopharma |
Bio Path and Immix Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bio Path and Immix Biopharma
The main advantage of trading using opposite Bio Path and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Path position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.| Bio Path vs. Capricor Therapeutics | Bio Path vs. NextCure | Bio Path vs. Pulmatrix | Bio Path vs. Crinetics Pharmaceuticals |
| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |